Nomura Holdings Inc. reduced its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,516 shares of the semiconductor company's stock after selling 989 shares during the period. Nomura Holdings Inc.'s holdings in Synopsys were worth $10,928,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. FNY Investment Advisers LLC purchased a new position in shares of Synopsys in the 4th quarter valued at about $140,000. Accurate Wealth Management LLC boosted its stake in shares of Synopsys by 14.8% during the fourth quarter. Accurate Wealth Management LLC now owns 939 shares of the semiconductor company's stock valued at $463,000 after acquiring an additional 121 shares during the last quarter. Floyd Financial Group LLC purchased a new position in Synopsys during the fourth quarter worth approximately $647,000. CCLA Investment Management lifted its stake in shares of Synopsys by 22.1% during the fourth quarter. CCLA Investment Management now owns 285,047 shares of the semiconductor company's stock worth $138,222,000 after purchasing an additional 51,620 shares in the last quarter. Finally, Board of the Pension Protection Fund acquired a new stake in Synopsys during the 4th quarter valued at approximately $1,019,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
SNPS has been the subject of several research analyst reports. Rosenblatt Securities reiterated a "buy" rating and set a $660.00 target price on shares of Synopsys in a research note on Tuesday, February 25th. Piper Sandler reduced their price objective on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Bank of America decreased their price objective on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a report on Wednesday, April 16th. KeyCorp increased their price target on shares of Synopsys from $555.00 to $575.00 and gave the stock an "overweight" rating in a research report on Tuesday. Finally, Wells Fargo & Company dropped their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $614.86.
Read Our Latest Research Report on SNPS
Synopsys Price Performance
Shares of SNPS traded down $3.34 during midday trading on Tuesday, reaching $512.67. The stock had a trading volume of 258,309 shares, compared to its average volume of 1,103,582. The firm's 50 day moving average price is $446.11 and its 200-day moving average price is $488.94. The company has a market capitalization of $79.27 billion, a P/E ratio of 35.31, a P/E/G ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80.
Insider Transactions at Synopsys
In related news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. The trade was a 13.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total value of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This trade represents a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by insiders.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.